Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS)
India flag India · Delayed Price · Currency is INR
640.10
+30.45 (4.99%)
Nov 22, 2024, 9:15 AM IST

AKUMS Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
40,79241,78236,54836,71927,226
Other Revenue
34.834.823.733.2935.83
Revenue
40,82741,81736,57236,75227,262
Revenue Growth (YoY)
2.39%14.34%-0.49%34.81%-
Cost of Revenue
25,17126,20423,49324,14517,343
Gross Profit
15,65615,61313,07912,6079,919
Selling, General & Admin
7,2776,9186,2915,3994,541
Other Operating Expenses
3,8813,8483,7653,1042,424
Operating Expenses
12,50312,02311,1849,4497,663
Operating Income
3,1543,5901,8953,1582,256
Interest Expense
-493.75-502.51-459.73-163.38-63.88
Interest & Investment Income
119.99119.9978.846.3161.44
Earnings From Equity Investments
---2.032.033.47
Currency Exchange Gain (Loss)
72.0572.05-38.9326.4627.36
Other Non Operating Income (Expenses)
-899.31-3,526490.16-4,883-490.62
EBT Excluding Unusual Items
1,953-246.181,963-1,8131,794
Impairment of Goodwill
----129.77-100
Gain (Loss) on Sale of Investments
----0.77
Gain (Loss) on Sale of Assets
-3.17-3.1745.75-20.66-4.04
Asset Writedown
-7.23-7.23-722.6410.55-
Other Unusual Items
112.45-196.2216.812132.16
Pretax Income
2,055-452.781,503-1,9321,723
Income Tax Expense
-779.29-460.68524.8576.77488.26
Earnings From Continuing Operations
2,8347.9978.17-2,5091,234
Minority Interest in Earnings
-56.29-48.25-29.62-16.62-7.3
Net Income
2,778-40.35948.55-2,5251,227
Net Income to Common
2,778-40.35948.55-2,5251,227
Shares Outstanding (Basic)
145143143143143
Shares Outstanding (Diluted)
145143143143143
Shares Change (YoY)
1.06%----
EPS (Basic)
19.21-0.286.63-17.658.58
EPS (Diluted)
19.21-0.286.63-17.658.58
Free Cash Flow
1,8241,869-1,522-2,257478.04
Free Cash Flow Per Share
12.6213.06-10.64-15.783.34
Gross Margin
38.35%37.34%35.76%34.30%36.38%
Operating Margin
7.72%8.59%5.18%8.59%8.28%
Profit Margin
6.80%-0.10%2.59%-6.87%4.50%
Free Cash Flow Margin
4.47%4.47%-4.16%-6.14%1.75%
EBITDA
4,3844,7332,9084,0052,880
EBITDA Margin
10.74%11.32%7.95%10.90%10.57%
D&A For EBITDA
1,2301,1421,013846.75624.48
EBIT
3,1543,5901,8953,1582,256
EBIT Margin
7.72%8.59%5.18%8.59%8.28%
Effective Tax Rate
--34.92%-28.34%
Revenue as Reported
41,18442,12237,00936,94527,438
Advertising Expenses
-389.87354.65294.51257.82
Source: S&P Capital IQ. Standard template. Financial Sources.